Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucose consumption in recurrent gliomas

M Ishikawa1, H Kikuchi, S Miyatake

  • 1Department of Neurosurgery, Faculty of Medicine, Kyoto University, Japan.

Neurosurgery
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone morphogenetic proteins (BMP-2 and BMP-3) induce the late phase expression of the proto-oncogene c-fos in murine osteoblastic MC3T3-E1 cells.

FEBS letters·1992
Same author

The effect of active vitamin D3 analogs and dexamethasone on the expression of osteocalcin gene in rat tibiae in vivo.

Biochemical and biophysical research communications·1992
Same author

Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae.

Endocrinology·1992
Same author

Possible activity of acidic fibroblast growth factor as a progression factor rather than a transforming factor.

Biochemical and biophysical research communications·1992
Same author

Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro.

Stroke·1992
Same author

Skull base metastasis from gastric cancer--case report.

Neurologia medico-chirurgica·1992

Positron emission tomography with 18F-labeled fluorodeoxyglucose (FDG-PET) helps detect recurrent gliomas. High glucose consumption on FDG-PET indicates higher malignancy, while lower uptake may suggest longer survival but requires careful interpretation due to potential viable tumor cells.

Area of Science:

  • Neuro-oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Recurrent gliomas pose significant challenges in diagnosis and management.
  • Assessing tumor metabolic activity is crucial for understanding glioma behavior.

Purpose of the Study:

  • To evaluate the clinical significance of glucose consumption (GC) using 18F-FDG-PET in recurrent gliomas.
  • To correlate GC levels with histological malignancy and patient prognosis.

Main Methods:

  • 18 cases of histologically verified recurrent gliomas underwent 18F-FDG-PET imaging.
  • Tumor glucose consumption was categorized into four groups based on uptake levels.
  • GC was compared with histological findings and survival data.

Main Results:

Related Experiment Videos

  • Half of the recurrent gliomas showed low GC (Groups I/II), with two-thirds being high-grade.
  • High GC (Groups III/IV) correlated with higher histological malignancy.
  • While not statistically significant, lower GC was associated with longer patient survival.

Conclusions:

  • 18F-FDG-PET is valuable for detecting glioma recurrence and assessing histological malignancy.
  • Focal increases in GC are diagnostically important, even in small lesions.
  • Caution is advised as low GC areas may harbor viable tumor cells, and small masses might be missed due to PET resolution.